Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:58 PM
Ignite Modification Date:
2025-12-24 @ 4:58 PM
NCT ID:
NCT03823950
Eligibility Criteria:
Inclusion Criteria:
* Pediatric oncology patients will be eligible to participate in this study if they meet the following inclusion criteria:
1. are between the ages of birth and 21 years old
2. is diagnosed with an oncologic disease
3. is being treated at UMMC Children's Cancer Clinic
4. will receive G-CSF as part of their standard or experimental oncology treatment protocol between January 1, 2019 and December 31, 2019. Oncology treatment protocols are typically derived from the Children's Oncology Group standard of care or patients can be enrolled on a Children's Oncology Group treatment study.
5. is within first four courses of chemotherapy treatment
Exclusion Criteria:
* Patients will be excluded from the current study if:
1. G-CSF was added to their oncology treatment protocol due to previous complications but for whom G-CSF was not part of their original treatment protocol.
2. are being treated for relapsed disease
3. has clinical evidence of bone marrow involvement
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
21 Years
Study:
NCT03823950
Study Brief:
Protocol Section:
NCT03823950